11,764
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Z-line alterations and gastroesophageal reflux: an endoscopic population-based prospective cohort study

ORCID Icon, , , , , , , & show all
Pages 1065-1069 | Received 03 Jul 2019, Accepted 10 Aug 2019, Published online: 27 Aug 2019

References

  • Eluri S, Shaheen NJ. Barrett's esophagus: diagnosis and management. Gastrointest Endosc. 2017;85:889–903.
  • Pietro MD, Alzoubaidi D, Fitzgerald RC. Barrett’s Esophagus and cancer risk: how research advances can impact clinical practice. Gut Liver. 2014;8:356–370.
  • Fitzgerald RC. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut. 2005;54(Suppl 1):i21–i26.
  • Gorrepati VS, Sharma P. How should we report endoscopic results in patient’s with barrett’s esophagus? Dig Dis Sci. 2018;361:1–7.
  • Sampliner R. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002;97:1888–1895.
  • Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49:191–198.
  • Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol. 2016;111:30–50.
  • Fitzgerald RC, Di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7–42.
  • Ferguson MK, Durkin A. Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg. 2002;6:29–36.
  • Guda N, Partington S, Vakil NB. Inter- and intra-observer variability in the measurement of length at endoscopy: implications for the measurement of Barrett's esophagus. Gastrointest Endosc. 2004;59:655–658.
  • Wallner B, Sylvan A, Stenling R, et al. The Z-line appearance and prevalence of intestinal metaplasia among patients without symptoms or endoscopical signs indicating gastroesophageal reflux. Surg Endosc. 2001;15:886–889.
  • Wallner B, Sylvan A, Stenling R, et al. The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia. Scand J Gastroenterol. 2000;35:17–22.
  • Wallner B, Sylvan A, Stenling R, et al. A postfundoplication study on Z-line appearance and intestinal metaplasia in the gastroesophageal junction. Surg Laparosc Endosc Percutan Tech. 2001;11:235–241.
  • Wallner B, Sylvan A, Janunger K-G. Endoscopic assessment of the “Z-line” (squamocolumnar junction) appearance: reproducibility of the ZAP classification among endoscopists. Gastrointest Endosc. 2002;55:65–69.
  • Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.
  • Lee YC, Cook MB, Bhatia S, et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. Endoscopy. 2010;42:699–704.
  • Agreus L, Hellström PM, Talley NJ, et al. Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community. UEGJ. 2016;4:686–696.
  • Agréus L, Svärdsudd K, Nyren O, et al. Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care. 1993;11:252–262.
  • Wallner B. Endoscopically defined gastroesophageal junction coincides with the anatomical gastroesophageal junction. Surg Endosc. 2009;23:2155–2158.
  • Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.
  • Maes S, Sharma P, Bisschops R. Review: surveillance of patients with Barrett oesophagus. Best Pract Res Clin Gastroenterol. 2016;30:901–912.
  • Ganz RA, Allen JI, Leon S, et al. Barrett’s esophagus is frequently overdiagnosed in clinical practice: results of the Barrett”s Esophagus Endoscopic Revision (BEER) study. Gastrointest Endosc. 2014;79:565–573.
  • Varghese S, Lao-Sirieix P, Fitzgerald RC. Identification and clinical implementation of biomarkers for Barrett's esophagus. Gastroenterology. 2012;142:435–441.e2.
  • Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976;295:476–480.
  • Hansdotter I, Björ O, Andreasson A, et al. Hill classification is superior to the axial length of a hiatal hernia for assessment of the mechanical anti-reflux barrier at the gastroesophageal junction. Endosc Int Open. 2016;4:E311–E317.
  • Alvarez Herrero L, Curvers WL, van Vilsteren FGI, et al. Validation of the Prague C&M classification of Barrett's esophagus in clinical practice. Endoscopy. 2013;45:876–882.